Your browser doesn't support javascript.
Association of right ventricular dysfunction and pulmonary hypertension with adverse 30-day outcomes in COVID-19 patients.
Wats, Karan; Rodriguez, Daniel; Prins, Kurt W; Sadiq, Adnan; Fogel, Joshua; Goldberger, Mark; Moskovits, Manfred; Tootkaboni, Mahsa Pourabdollah; Shani, Jacob; Jacob, Jessen.
  • Wats K; Department of Cardiology, Heart and Vascular Institute, Maimonides Medical Center, Brooklyn, NY, USA.
  • Rodriguez D; Department of Cardiology, Heart and Vascular Institute, Maimonides Medical Center, Brooklyn, NY, USA.
  • Prins KW; Division of Cardiology, University of Minnesota, Minneapolis, MN, USA.
  • Sadiq A; Department of Cardiology, Heart and Vascular Institute, Maimonides Medical Center, Brooklyn, NY, USA.
  • Fogel J; Department of Business Management, Brooklyn College, Brooklyn, NY, USA.
  • Goldberger M; Department of Cardiology, Heart and Vascular Institute, Maimonides Medical Center, Brooklyn, NY, USA.
  • Moskovits M; Department of Cardiology, Heart and Vascular Institute, Maimonides Medical Center, Brooklyn, NY, USA.
  • Tootkaboni MP; Department of Medicine, Maimonides Medical Center, Brooklyn, NY, USA.
  • Shani J; Department of Cardiology, Heart and Vascular Institute, Maimonides Medical Center, Brooklyn, NY, USA.
  • Jacob J; Department of Cardiology, Heart and Vascular Institute, Maimonides Medical Center, Brooklyn, NY, USA.
Pulm Circ ; 11(2): 20458940211007040, 2021.
Article in English | MEDLINE | ID: covidwho-1215077
ABSTRACT

BACKGROUND:

Cardiac manifestations in COVID-19 are multifactorial and are associated with increased mortality. The clinical utility and prognostic value of echocardiography in COVID-19 inpatients is not clearly defined. We aim to identify echocardiographic parameters that are associated with 30-day clinical outcomes secondary to COVID-19 hospitalization.

METHODS:

This retrospective cohort study was conducted in a large tertiary hospital in New York City during the COVID-19 pandemic. It included 214 adult inpatients with a laboratory-confirmed diagnosis of COVID-19 by reverse transcriptase polymerase chain reaction assay (RT-PCR) for SARS-CoV-2 on nasopharyngeal swab and had a transthoracic echocardiogram performed during the index hospitalization. Primary outcome was 30-day all-cause inpatient mortality. Secondary outcomes were 30-day utilization of mechanical ventilator support, vasopressors, or renal replacement therapy.

RESULTS:

Mild right ventricular systolic dysfunction (odds ratio (OR) 3.51, 95% confidence interval (CI) 1.63-7.57, p = 0.001), moderate to severe right ventricular systolic dysfunction (OR 7.30, 95% CI 2.20-24.25, p = 0.001), pulmonary hypertension (OR 5.39, 95% CI 1.96-14.86, p = 0.001), and moderate to severe tricuspid regurgitation (OR 3.92, 95% CI 1.71-9.03, p = 0.001) were each associated with increased odds of 30-day all-cause inpatient mortality. Pulmonary hypertension and moderate to severe right ventricular dysfunction were each associated with increased odds of 30-day utilization of mechanical ventilator support and vasopressors.

CONCLUSIONS:

Right ventricular dysfunction, pulmonary hypertension, and moderate to severe tricuspid regurgitation were associated with increased odds for 30-day inpatient mortality. This study highlights the importance of echocardiography and its clinical utility and prognostic value for evaluating hospitalized COVID-19 patients.
Keywords

Full text: Available Collection: International databases Database: MEDLINE Type of study: Cohort study / Experimental Studies / Observational study / Prognostic study Language: English Journal: Pulm Circ Year: 2021 Document Type: Article Affiliation country: 20458940211007040

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Type of study: Cohort study / Experimental Studies / Observational study / Prognostic study Language: English Journal: Pulm Circ Year: 2021 Document Type: Article Affiliation country: 20458940211007040